Adjuvant Erlotinib Versus Placebo in Patients With Stage IB-IIIA Non-Small-Cell Lung Cancer (RADIANT): A Randomized, Double-Blind, Phase III Trial - Kelly, K; Altorki, N; Eberhardt, W (J Clin Oncol, 2015)
et al.